Skip to main content
Tech.euFundingExplorerBeta

Nuclera

Biotech company developing cutting-edge benchtop protein printing technologies

Nuclera has raised €133M across 5 funding rounds from 19 investors, most recently a Series C round in Jan 2026. Based in Cambridge, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€133M
€133,180,599
Funding rounds
5
Investors
19
distinct backers
Active since
2022-02
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
Nuclera — funding by year — interactive chart.
Data table
Nuclera — funding by year
2022€53M
2024€70M
2026€10M

Signals

High confidence
Raise-next likelihood49
base rate 50% for Series C
  • ▲ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood28
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 5 rounds raised
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.